List of SBIR/STTR awards granted to Novelmed Therapeutics Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc in July, 2021 for $533,165.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HL156774-01A1 | Phase I | 533,165 | July 15, 2021 | |||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc in June, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG072939-01 | Phase I | 300,000 | June 15, 2021 | |||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc in March, 2015 for $2,436,893.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HL122028-02 | Phase II | 2,436,893 | March 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc in August, 2014 for $1,451,573.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK082025-02A1 | Phase II | 1,451,573 | August 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc in September, 2014 for $588,124.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44EY024809-01 | Phase II | 588,124 | September 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc for $1,485,330.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL080934-02 | Phase II | 1,485,330 | ||||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc for $307,870.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG041564-02 | Phase II | 307,870 | ||||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc for $825,534.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR048476-02 | Phase II | 825,534 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $273,190.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL097512-01 | Phase I | 273,190 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $420,195.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HL099015-01 | Phase I | 420,195 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $294,766.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG041564-01 | Phase I | 294,766 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $542,572.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HL115909-01A1 | Phase I | 542,572 | ||||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc for $1,064,251.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44EY019191-02A1 | Phase II | 1,064,251 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $249,927.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR056917-01 | Phase I | 249,927 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $208,148.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41HL081972-01 | Phase I | 208,148 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $791,681.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG039118-01A1 | Phase I | 791,681 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $266,001.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM090341-01A1 | Phase I | 266,001 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI085697-01 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $233,538.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK082025-01A1 | Phase I | 233,538 | ||||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc for $1,352,967.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HL099015-02 | Phase II | 1,352,967 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $206,911.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL080934-01 | Phase I | 206,911 | ||||||||
A STTR Phase I contract was awarded to Novelmed Therapeutics Inc for $208,148.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL081972-01 | Phase I | 208,148 | ||||||||
A SBIR Phase II contract was awarded to Novelmed Therapeutics Inc for $889,438.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HL115909-02 | Phase II | 889,438 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $548,724.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44EY024809-01 | Phase I | 548,724 | ||||||||
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc for $103,103.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR048476-01A1 | Phase I | 103,103 |
